KC
CELG

Kepos Capital’s Celgene Corp CELG Stock Holding History

Kepos Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-27,071
Closed -$2.5M – 437
2019
Q2 		$2.5M Sell
27,071
-394,849
-94% -$37.5M 0.25% 92
2019
Q1 		$39.8M Buy
+421,920
New +$36.9M 2.98% 5
2018
Q3 		– Sell
-16,960
Closed -$1.35M – 459
2018
Q2 		$1.35M Buy
16,960
+5,057
+42% +$420K 0.07% 201
2018
Q1 		$1.06M Sell
11,903
-33,569
-74% -$3.22M 0.06% 172
2017
Q4 		$4.75M Buy
45,472
+40,667
+846% +$4.59M 0.43% 34
2017
Q3 		$701K Buy
+4,805
New +$654K 0.12% 70

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kepos Capital's CELG Position: Q3 2019 in Review

Kepos Capital sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 27,071 shares — an estimated $2.5M sold.

Kepos Capital first reported a position in CELG in Q3 2017 and held it in 6 quarters. The position peaked at $39.8M in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Kepos Capital reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Kepos Capital sold 27,071 Celgene Corp shares in Q3 2019, an estimated $2.5M.
  • Kepos Capital first reported a position in Celgene Corp in Q3 2017 and held it in 6 quarters.
  • Kepos Capital's Celgene Corp position peaked at $39.8M in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Kepos Capital's 13F filing for Q3 2019, filed 13 Nov 2019.